
S29434
CAS No. 874484-20-5
S29434 ( —— )
产品货号. M20697 CAS No. 874484-20-5
S29434 (NMDPEF) 是一种有效的醌还原酶 2 (QR2;IC50:5-16nM) 竞争性抑制剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥988 | 有现货 |
![]() ![]() |
10MG | ¥1596 | 有现货 |
![]() ![]() |
25MG | ¥3208 | 有现货 |
![]() ![]() |
50MG | ¥4771 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称S29434
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述S29434 (NMDPEF) 是一种有效的醌还原酶 2 (QR2;IC50:5-16nM) 竞争性抑制剂。
-
产品描述S29434 (NMDPEF) is a potent competitiveinhibitor of quinone reductase 2 (QR2;IC50:5-16nM).
-
体外实验Cell Autophagy Assay Cell Line:HepG2 cell line Concentration:5 and 10 μM Incubation Time:24 hours Result:Mitochondrial ROS-independently and QR2-dependently triggered autophagy, and dose-dependently induced LC3-II which is a marker of autophagy vesicles.
-
体内实验Animal Model:CH3 wild-type mice Dosage:1 and 15 mg/kg Administration:Intraperitoneal injection; 1 and 15 mg/kg once Result:Positively affected memory by inhibiting QR2.
-
同义词——
-
通路Membrane Transporter/Ion Channel
-
靶点NADPH
-
受体Quinone reductase 2(QR2)
-
研究领域——
-
适应症——
化学信息
-
CAS Number874484-20-5
-
分子量374.39
-
分子式C21H18N4O3
-
纯度>98% (HPLC)
-
溶解度DMSO:12.5 mg/mL?(33.39 mM)
-
SMILESCOc1ccc2n3Cc4cccnc4-c3c(CCNC(=O)c3ccco3)c2n1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Boutin JA Bouillaud F Janda Eet al.S29434 a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization[J].Mol Pharmacol. 2019 Mar;95(3):269-285.
产品手册




关联产品
-
GKT137831
GKT137831 (Setanaxib, GKT-137831) 是一种有效的、选择性的双 NADPH 氧化酶 Nox1/4 抑制剂,Ki 为 110/140 nM。
-
NoxA1ds
Potent and selective NADPH oxidase 1 (NOX1) inhibitor (IC50 = 20 nM). Exhibits selectivity for NOX1 over NOX2, NOX4, NOX5 and xanthine oxidase. Inhibits NOX1-derived O2- production in HT-29 human colon cancer cells. Attenuates VEGF-induced human pulmonary artery endothelial cell migration under hypoxic conditions in vitro. Cell permeable.
-
AKR1C3-IN-4
AKR1C3-IN-4 是一种有效的选择性醛酮还原酶 1C3 (AKR1C3) 抑制剂,IC 50 为 0.56 μM。 AKR1C3-IN-4 具有用于去势抵抗性前列腺癌 (CRPC) 研究的潜力。